Prudential PLC (LSE: PRU) published its third-quarter business performance update on 5 November 2026, reporting new business profit (NBP) of $709 million for the three months ended 30 September 2026, up 1 per cent on a constant exchange rate basis. Year-to-date NBP reached $2,093 million, representing 6 per cent growth, supported by a 3 percentage point expansion in new business margin. However, the insurer flagged that its Chinese Mainland life operations faced significant headwinds from regulatory changes to bancassurance expense controls, making its full-year double-digit growth guidance more stretching than previously anticipated. Investors will be watching whether Q4 momentum in China and broader ASEAN markets can close the gap before year end.

Key Points

  • Prudential PLC (LSE: PRU; HKEX: 2378) — pan-Asian life and health insurer and asset manager
  • Q3 2026 group new business profit of $709 million, up 1 per cent on a constant exchange rate basis; year-to-date NBP up 6 per cent at $2,093 million
  • FY26 NBP from Chinese Mainland operations (CITIC Prudential Life) now expected to be 10–15 per cent lower than 2025; group FY26 double-digit growth guidance described as "more stretching than anticipated"
  • Investors should watch Q4 Chinese Mainland recovery pace, Eastspring FUM trends, and progress on the Bharti Life acquisition approvals in India

Chinese Mainland Bancassurance Regulation Weighs on CITIC Prudential Life's Q3 New Business Profit

Prudential's joint venture in China, CITIC Prudential Life, saw new business profit decline significantly in Q3 2026 as revised bancassurance expense regulations constrained sales volumes, compounded by a high prior-year comparator from July and August 2025. The company now expects full-year 2026 new business profit from Chinese Mainland operations to be approximately 10 to 15 per cent below 2025 levels. Despite this, the announcement states that new business profit margin in Q3 exceeded 40 per cent, and that strong APE sales momentum in September and October supports confidence that Q4 will return to growth, albeit at a slower rate than previously anticipated.

Bancassurance Channel and ASEAN Markets Drive Prudential's Ex-China NBP Growth of 13% in Q3

Excluding Chinese Mainland operations, Prudential delivered NBP growth of 13 per cent in Q3 and 11 per cent year to date, with the bancassurance channel outside China growing new business profit by more than 20 per cent in the quarter. Hong Kong domestic demand remained resilient, with year-to-date NBP up double-digit, supported by repricing and higher bancassurance margins. Malaysia delivered another quarter of double-digit NBP growth, driven by health and protection sales to the mass affluent segment. Thailand showed strong momentum through new product launches, while Vietnam returned to growth in both sales and NBP in Q3 compared with the same period in 2025.

Eastspring FUM Falls to $285.7bn at Quarter End Despite $5.4bn Net Inflows

Prudential's asset management arm, Eastspring, ended the third quarter with funds under management or advice of $285.7 billion, down from $290.8 billion at 30 June 2026. The announcement states that strong net inflows of $5.4 billion from both the group's insurance businesses and third parties were more than offset by adverse market movements, including rising interest rates, and a $2.6 billion FUM reduction linked to Prudential's sale of a 2.0 per cent stake in ICICI Prudential Asset Management Company, which reduced Prudential's ownership in IPAMC to 32.6 per cent following the transaction announced on 27 August 2026.

Prudential Reaffirms FY26 Guidance and $1.5bn Share Buyback as India Acquisition Progresses

Despite the China headwind, Prudential reaffirmed its commitment to full-year 2026 double-digit growth guidance across its four Key Financial Metrics, which include new business profit, operating free surplus generated from in-force insurance and asset management, earnings per share based on adjusted operating profit, and dividend per share. The group stated that year-to-date share buybacks reached $1.0 billion for the nine months to 30 September 2026, with the total expected to reach $1.5 billion by year end. In India, regulatory approvals for the acquisition of a controlling interest in Bharti Life are progressing, and a standalone health business has been successfully launched.